Gauge dependence of calculations in relativistic Coulomb excitation

Before a quantum-mechanical calculation involving electromagnetic interactions is performed, a choice must be made of the gauge to be used in expressing the potentials. If the calculation is done exactly, the observable results it predicts will be independent of the choice of gauge. However, in most practical calculations approximations are made, which can destroy the gauge invariance of the predictions. We compare here the results of coupled-channel time-dependent relativistic Coulomb excitation calculations, as performed in either Lorentz or Coulomb gauges. We find significant differences when the bombarding energy per nucleon is $\geq$ 2 GeV, which indicates that the common practice of relying completely on the Lorentz gauge can be dangerous.Comment: 23 pages, 3 figure

Coulomb Excitation of Multi-Phonon Levels of the Giant Dipole Resonance

A closed expression is obtained for the cross-section for Coulomb excitation of levels of the giant dipole resonance of given angular momentum and phonon number. Applications are made to the Goldhaber-Teller and Steinwedel-Jensen descriptions of the resonance, at non-relativistic and relativistic bombarding energies.Comment: 16 pages, 5 figure

Symmetry-breaking skyrmion states in fractional quantum Hall systems

We calculate in an analyical fashion the energies and net spins of skyrmions in fractional quantum Hall systems, based on the suggestion that skyrmion states are spontaneously $L_Z$ and $S_Z$ symmetry-breaking states. The quasihole-skyrmion state with a charge $-e/3$ around $\nu$ = 1/3, where the ground state is known as a spin-polarized ferromagnetic state, is found to exist even in high magnetic fields up to about 7 T for GaAs samples.Comment: There is conceptual change. To appear in Phys. Rev.

Quadrupole Collective States in a Large Single-J Shell

We discuss the ability of the generator coordinate method (GCM) to select collective states in microscopic calculations. The model studied is a single-$j$ shell with hamiltonian containing the quadrupole-quadrupole interaction. Quadrupole collective excitations are constructed by means of the quadrupole single-particle operator. Lowest collective bands for $j$=31/2 and particle numbers $N$=4,6,8,10,12, and $14$ are found. For lower values of $j$, exact solutions are obtained and compared with the GCM results.Comment: submitted for publication in Phys. Rev. C, revtex, 28 pages, 15 PostScript figures available on request from [email protected], preprint No. IFT/17/9

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

Background Whole brain radiotherapy (WBRT) and dexamethasone are widely used to treat brain metastases from non-small cell lung cancer (NSCLC), although there have been no randomised clinical trials showing that WBRT improves either quality of life or overall survival. Even after treatment with WBRT, the prognosis of this patient group is poor. We aimed to establish whether WBRT could be omitted without a signifi cant eff ect on survival or quality of life. Methods The Quality of Life after Treatment for Brain Metastases (QUARTZ) study is a non-inferiority, phase 3 randomised trial done at 69 UK and three Australian centres. NSCLC patients with brain metastases unsuitable for surgical resection or stereotactic radiotherapy were randomly assigned (1:1) to optimal supportive care (OSC) including dexamethasone plus WBRT (20 Gy in five daily fractions) or OSC alone (including dexamethasone). The dose of dexamethasone was determined by the patients’ symptoms and titrated downwards if symptoms improved. Allocation to treatment group was done by a phone call from the hospital to the Medical Research Council Clinical Trials Unit at University College London using a minimisation programme with a random element and stratifi cation by centre, Karnofsky Performance Status (KPS), gender, status of brain metastases, and the status of primary lung cancer. The primary outcome measure was quality-adjusted life-years (QALYs). QALYs were generated from overall survival and patients’ weekly completion of the EQ-5D questionnaire. Treatment with OSC alone was considered noninferior if it was no more than 7 QALY days worse than treatment with WBRT plus OSC, which required 534 patients (80% power, 5% [one-sided] signifi cance level). Analysis was done by intention to treat for all randomly assigned patients. The trial is registered with ISRCTN, number ISRCTN3826061. Findings Between March 2, 2007, and Aug 29, 2014, 538 patients were recruited from 69 UK and three Australian centres, and were randomly assigned to receive either OSC plus WBRT (269) or OSC alone (269). Baseline characteristics were balanced between groups, and the median age of participants was 66 years (range 38–85). Signifi cantly more episodes of drowsiness, hair loss, nausea, and dry or itchy scalp were reported while patients were receiving WBRT, although there was no evidence of a difference in the rate of serious adverse events between the two groups. There was no evidence of a diff erence in overall survival (hazard ratio 1·06, 95% CI 0·90–1·26), overall quality of life, or dexamethasone use between the two groups. The diff erence between the mean QALYs was 4·7 days (46·4 QALY days for the OSC plus WBRT group vs 41·7 QALY days for the OSC group), with two-sided 90% CI of –12·7 to 3·3. Interpretation Although the primary outcome measure result includes the prespecifi ed non-inferiority margin, the combination of the small diff erence in QALYs and the absence of a diff erence in survival and quality of life between the two groups suggests that WBRT provides little additional clinically signifi cant benefi t for this patient group

Ballistic matter waves with angular momentum: Exact solutions and applications

An alternative description of quantum scattering processes rests on inhomogeneous terms amended to the Schroedinger equation. We detail the structure of sources that give rise to multipole scattering waves of definite angular momentum, and introduce pointlike multipole sources as their limiting case. Partial wave theory is recovered for freely propagating particles. We obtain novel results for ballistic scattering in an external uniform force field, where we provide analytical solutions for both the scattering waves and the integrated particle flux. Our theory directly applies to p-wave photodetachment in an electric field. Furthermore, illustrating the effects of extended sources, we predict some properties of vortex-bearing atom laser beams outcoupled from a rotating Bose-Einstein condensate under the influence of gravity.Comment: 42 pages, 8 figures, extended version including photodetachment and semiclassical theor

Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma

OBJECTIVES: The limited positive predictive value of an incomplete response on PET-CT following (chemo)radiotherapy for head and neck squamous cell carcinoma (HNSCC) means that the optimal management strategy remains uncertain. The aim of the study is to assess the utility of a 'second-look' interval PET-CT. METHODS: Patients with HNSCC who were treated with (chemo)radiotherapy between 2008 and 2017 and underwent (i) baseline and (ii) response assessment PET-CT and (iii) second-look PET-CT following incomplete (positive or equivocal scan) response were included. Endpoints were conversion rate to complete response (CR) and test characteristics of the second-look PET-CT. RESULTS: Five hundred sixty-two patients with HNSCC underwent response assessment PET-CT at a median of 17 weeks post-radiotherapy. Following an incomplete response on PET-CT, 40 patients underwent a second-look PET-CT at a median of 13 weeks (range 6-25) from the first response PET-CT. Thirty-four out of 40 (85%) patients had oropharyngeal carcinoma. Twenty-four out of 40 (60%) second-look PET-CT scans converted to a complete locoregional response. The primary tumour conversion rate was 15/27 (56%) and the lymph node conversion rate was 14/19 (74%). The sensitivity, specificity, positive predictive value and negative predictive value (NPV) of the second-look PET-CT were 75%, 75%, 25% and 96% for the primary tumour and 100%, 92%, 40% and 100% for lymph nodes. There were no cases of progression following conversion to CR in the primary site or lymph nodes. CONCLUSIONS: The majority of patients who undergo a second-look PET-CT convert to a CR. The NPV of a second-look PET-CT is high, suggesting the potential to avoid surgical intervention. KEY POINTS: • PET-CT is a useful tool for response assessment following (chemo)radiotherapy for head and neck squamous cell carcinoma. • An incomplete response on PET-CT has a limited positive predictive value and optimal management is uncertain. • These data show that with a 'second-look' interval PET-CT, the majority of patients convert to a complete metabolic response. When there is doubt about clinical and radiological response, a 'second-look' PET-CT can be used to spare patients unnecessary surgical intervention

4β-Hydroxywithanolide E from Physalis peruviana (golden berry) inhibits growth of human lung cancer cells through DNA damage, apoptosis and G2/M arrest

<p>Abstract</p> <p>Background</p> <p>The crude extract of the fruit bearing plant, <it>Physalis peruviana </it>(golden berry), demonstrated anti-hepatoma and anti-inflammatory activities. However, the cellular mechanism involved in this process is still unknown.</p> <p>Methods</p> <p>Herein, we isolated the main pure compound, 4β-Hydroxywithanolide (4βHWE) derived from golden berries, and investigated its antiproliferative effect on a human lung cancer cell line (H1299) using survival, cell cycle, and apoptosis analyses. An alkaline comet-nuclear extract (NE) assay was used to evaluate the DNA damage due to the drug.</p> <p>Results</p> <p>It was shown that DNA damage was significantly induced by 1, 5, and 10 μg/mL 4βHWE for 2 h in a dose-dependent manner (<it>p </it>< 0.005). A trypan blue exclusion assay showed that the proliferation of cells was inhibited by 4βHWE in both dose- and time-dependent manners (<it>p </it>< 0.05 and 0.001 for 24 and 48 h, respectively). The half maximal inhibitory concentrations (IC₅₀) of 4βHWE in H1299 cells for 24 and 48 h were 0.6 and 0.71 μg/mL, respectively, suggesting it could be a potential therapeutic agent against lung cancer. In a flow cytometric analysis, 4βHWE produced cell cycle perturbation in the form of sub-G₁accumulation and slight arrest at the G₂/M phase with 1 μg/mL for 12 and 24 h, respectively. Using flow cytometric and annexin V/propidium iodide immunofluorescence double-staining techniques, these phenomena were proven to be apoptosis and complete G₂/M arrest for H1299 cells treated with 5 μg/mL for 24 h.</p> <p>Conclusions</p> <p>In this study, we demonstrated that golden berry-derived 4βHWE is a potential DNA-damaging and chemotherapeutic agent against lung cancer.</p